To Explore a Bridging Index for the Effectiveness of the Clinical Trial

Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years

NCT03344029 ·Status: COMPLETED ·Phase: PHASE4

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1

Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older

NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years

NCT00719043 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

NCT02883426 ·Status: TERMINATED ·Phase: PHASE1

Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers

NCT02822105 ·Status: COMPLETED ·Phase: PHASE1

A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)

NCT02964065 ·Status: COMPLETED ·Phase: PHASE3

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

NCT04210349 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

NCT04363359 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of A Quadrivalent Influenza Vaccine

NCT03744104 ·Status: COMPLETED ·Phase: PHASE3

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

NCT02480101 ·Status: COMPLETED ·Phase: PHASE1

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

NCT06602024 ·Status: COMPLETED ·Phase: PHASE3

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

NCT01594320 ·Status: COMPLETED ·Phase: PHASE1

Post-License Safety Evaluation of Influenza Virus Vaccine

NCT02136017 ·Status: COMPLETED

Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

NCT02151344 ·Status: COMPLETED ·Phase: PHASE1

A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

NCT03755427 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

NCT00644059 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations

NCT01746082 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

NCT03859141 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

NCT01236040 ·Status: COMPLETED ·Phase: PHASE1

Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

NCT07327398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

NCT07204964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine

NCT01982331 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

NCT03853993 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

NCT01776541 ·Status: COMPLETED ·Phase: PHASE2